Study sheds light on how MSCs suppress inflammation long after they leave the body

Study sheds light on how MSCs suppress inflammation long after they leave the body
Monocytes and macrophages engulf cytoplasmic components of mesenchymal stromal cells (MSCs) and are reprogrammed to suppress a T cell response. A 3D reconstruction and surface rendering of a confocal z-stack from monocytes and macrophages (green) cocultured with MSCs derived from human umbilical cord tissue. Prior to co-culturing, the MSCs were stained with the cytoplasmic marker Qtracker (red). Credit: AlphaMed Press

A new study released today in Stem Cells might just have solved the mystery behind why mesenchymal stem cells (MSCs) continue to suppress inflammation in the body long after the MSCs are cleared from the system. The findings, by researchers at Duke University (Durham, N.C.), could help overcome a critical barrier to MSCs being considered a reliable option when developing treatments for inflammatory diseases ranging from COVID-19 and cancer, to allergies, arthritis and more.

MSCs are that can be isolated from bone marrow, adipose and other tissue sources. Their ability to differentiate into a variety of cell types, along with their capability to self-renew, repair and heal, make them attractive candidates for therapeutic use.

However, there's a drawback, researchers say.

"While MSCs are widely used in due to their ability to modulate inflammation, their success over the past 25 years has been varied—something that is likely a result of us not being able to totally understand how they work," said Anthony Filiano, Ph.D. He and Hyunjung Min, Ph.D., in Duke's Marcus Center for Cellular Cures, were co-leaders of the current study.

The ability for MSCs to suppress T cells is well documented in the lab, but little is known how they function in the body. "What we do know," Dr. Filiano continued, "is that after MSCs are injected into the body, they travel to the lungs and other tissues and then are rapidly cleared. Despite this, MSCs suppress the long-term. If the reason behind why and how this is happening can be determined, the information could be very helpful in developing new treatments for a variety of ."

In search of an answer, the Duke team injected human cord tissue-derived MSCs (hCT-MSCs) into mice with induced lung inflammation. Twenty-four hours later when the mouse lungs were analyzed, "We found that pieces of the MSCs had been engulfed by monocytes and macrophages (types of disease-fighting cells), in effect clearing them from the animals' systems," Dr. Min reported. "We also noted long-term transcription changes in the cells that ate pieces of MSCs suppressed the activation of T cells." (Transcription is the process by which the information in a strand of DNA is copied into a new molecule of messenger RNA.)

Next, using a combination of computational and pharmacological approaches, the researchers identified potential receptors on monocytes and macrophages that mediated their interactions with the hCT-MSCs and blocked interaction with a pharmacological inhibitor. They also identified a key cytoplasmic organelle in hCT-MSCs necessary to reprogram the monocytes and macrophages.

"Our results shed light on how MSCs can modulate the inflammatory response without long-term engraftment using a previously undescribed form of cell communication," said Dr. Filiano, "and explain how MSCs have extended beneficial effects on the body despite being cleared just hours after administration."

Dr. Jan Nolta, Editor-in-Chief of STEM CELLS, said, "this study, which determines a mechanism by which the effects of MSCs on immune modulation are extended after the themselves are physically cleared, brings clarity to an longstanding and important question in the field. We congratulate the authors for this important report."

Explore further

Study reveals fibulin 5 is required for Schwann cells' myelination

More information: Stem Cells (2020). DOI: 10.1002/stem.3292
Journal information: Stem Cells

Provided by AlphaMed Press
Citation: Study sheds light on how MSCs suppress inflammation long after they leave the body (2020, November 9) retrieved 20 April 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments